Targeted therapy for NSCLC with EGFR mutations, Third-generation irreversible EGFR-TKI, Effective against central nervous system metastasis, Indicated for EGFR Ex19Del or EGFR L858R mutations,
Sale!
Lucius
Replica Osimertinib Targeted EGFR-TKI for NSCLC
Original price was: $627.00.$468.00Current price is: $468.00.
Targeted therapy for NSCLC with EGFR mutations, Third-generation irreversible EGFR-TKI, Effective against central nervous system metastasis, Indicated for EGFR Ex19Del or EGFR L858R mutations,
Reviews
There are no reviews yet.